Private Wealth Advisors (California)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,348
Closed -$201K 72
2023
Q3
$201K Buy
+1,348
New +$198K 0.09% 74
2023
Q2
Sell
-1,349
Closed -$215K 80
2023
Q1
$215K Buy
1,349
+5
+0.4% +$764 0.09% 74
2022
Q4
$217K Buy
+1,344
New +$206K 0.07% 75
2022
Q2
Sell
-1,324
Closed -$215K 82
2022
Q1
$215K Buy
+1,324
New +$192K 0.07% 72
2021
Q4
Sell
-11,418
Closed -$1.33M 98
2021
Q3
$1.33M Sell
11,418
-92
-0.8% -$10.5K 0.32% 56
2021
Q2
$1.3M Buy
11,510
+1,241
+12% +$140K 0.4% 48
2021
Q1
$1.11M Buy
+10,269
New +$1.1M 0.38% 45

Other funds holding ABBV

Private Wealth Advisors (California)'s ABBV Position: Q4 2023 in Review

Private Wealth Advisors (California) sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 1,348 shares — an estimated $201K sold.

Private Wealth Advisors (California) first reported a position in ABBV in Q1 2021 and held it in 7 quarters. The position peaked at $1.33M in Q3 2021. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Private Wealth Advisors (California) reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • Private Wealth Advisors (California) sold 1,348 AbbVie shares in Q4 2023, an estimated $201K.
  • Private Wealth Advisors (California) first reported a position in AbbVie in Q1 2021 and held it in 7 quarters.
  • Private Wealth Advisors (California)'s AbbVie position peaked at $1.33M in Q3 2021.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Private Wealth Advisors (California)'s 13F filing for Q4 2023, filed 23 Jan 2024.